𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunohistochemical demonstration of relaxin in gynecologic tumors

✍ Scribed by Hannele Yki-Järvinen; Torsten Wahlström; Markku Seppälä

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
1013 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunohistochemical demonstration of neu
Immunohistochemical demonstration of neuron-specific enolase in gynecologic malignant tumors
✍ Masaki Inoue; Gaiko Ueda; Takashi Nakajima 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

Gynecologic malignant tumors were studied by the immunoperoxidase method for neuron-specific enolase (NSE). They included 22 argyrophil cell carcinomas of the endometrium, 6 argyrophil small cell carcinomas of the cervix, 21 argyrophil cell adenocarcinomas of the ovary (endometrioid type, 10; mucino

Immunohistochemical demonstration of alp
Immunohistochemical demonstration of alpha-1-proteinase inhibitor in brain tumors
✍ Mario Zuccarello; Raymond Sawaya; Mukunda B. Ray 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 965 KB

Using light microscopy and immunoperoxidase methods (PAP), the presence of alpha-1-proteinase inhibitor (API) was studied in seventeen brain tumors and four normal brain samples. The brain tumors included four glioblastomas, five low-grade gliomas, two metastatic lung carcinomas, two acoustic schwan

Circulating tumor markers in the monitor
Circulating tumor markers in the monitoring of gynecologic malignancies
✍ Peter E. Schwartz; Setsuko K. Chambers; Joseph T. Chambers; Jacqueline Gutmann; 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 751 KB

Plasma from 262 patients with gynecologic malignancies was assayed for levels of circulating tumor markers (CA 125, LSA [lipid associated sialic acid in plasma, LASA-P (Dianon Systems, Inc., Stratford, CT )], Ca 19-9, and carcinoembryonic antigen [CEA]) and correlated with the patients' clinical sta

Clinical importance of molecular determi
Clinical importance of molecular determinations in gynecologic patients with multiple tumors
✍ Winand N. M. Dinjens; Maria E. L. van der Burg; Savi Chadha; Hein F. B. M. Sledd 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 1014 KB

## Abstract ## BACKGROUND The prognosis and treatment of patients with multiple tumors may depend on the correlation between tumors: multiple primary tumors, or recurrent tumors, and metastatic disease. The authors investigated whether the detection of molecular aberrations in multiple gynecologic